SFX by Ex Libris Inc.

Title:	CCR5 promoter alleles and specific DNA binding factors
Source:	Science [0036-8075] Bream, J H yr:2004

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Paxton, Y A. "The role of a mutant CCR5 allele in HIV-1 transmission and disease progression." Nature medicine 2.11 (1996): 1240-3.
description	2.	Han, C. "Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells." Journal of cellular physiology 207.1 (2006): 261-70.
description	3.	Gallo, R C C. "HIV infection and pathogenesis: what about chemokines?" Journal of Clinical Immunology 19.5 (1999): 293-9.
description	4.	Gonzalez, E. "The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility." Science 307.5714 (2005): 1434-40.
description	5.	Smith, J. O'Brien W. "Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression." Science 277.5328 (1997): 959-965.
description	6.	Liu, S. "Effect of CCR5-Î32 Heterozygosity on HIV-1 Susceptibility: A Meta-Analysis." PLoS ONE 7.4 (2012).
description	7.	O'Brien, S J. "Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)." Science 279.5349 (1998): 389-93.
description	8.	Townson, J. "Gene copy number regulates the production of the human chemokine CCL3-L1." European journal of immunology 32.10 (2002): 3016-26.
description	9.	Berger, E A A. "Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease." Annual review of immunology 17.1 (1999): 657-700.
description	10.	Nelson, George W W. "Human genes that limit AIDS." Nature genetics 36.6 (2004): 565-74.
description	11.	Gruters, Rob A. "HIV and smallpox." Science 308.5726 (2005): 1258-9.
description	12.	Dean, M. "Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE." Science 273.5283 (1996): 1856-62.
description	13.	GALVANI, Alison P P. "Evaluating plague and smallpox as historical selective pressures for the CCR 5-Δ 32 HIV-resistance allele." Proceedings of the National Academy of Sciences of the United States of America 100.25 (2003): 15276-9.
description	14.	Schliekelman, P. "Natural selection and resistance to HIV." Nature 411.6837 (2001): 545-546.
description	15.	Arenzana-Seisdedos, F. "Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands." Seminars in immunology 18.6: 387-403.
description	16.	Gonzalez, E. "Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic." Proceedings of the National Academy of Sciences of the United States of America 98.9 (2001): 5199-204.
description	17.	Price, R W. "AIDS dementia complex (ADC) and HIV infection of the CNS: Pathophysiologically-based approach to treatment and evaluation." Electroencephalography and clinical neurophysiology 103.1: 27-27.
description	18.	Kwok, Amy H. Y. H. "Molecular characterization of prostaglandin F receptor (FP) and E receptor subtype 1 (EP(1)) in zebrafish." General and comparative endocrinology 178.2 (2012): 216-26.
description	19.	Aquaro, S. "The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages." Journal of virology (2001): 4402-6.
description	20.	Mummidi S, S. "Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression." Nature medicine 4.7 (1998): 786-93.